IN3 East 2011

Alandra Medical, Inc.

First Time Presenter

Palo Alto, CA

Alandra Medical is at the forefront of the medtech innovation offshoring trend in offering capital efficient design, deveopment and clinical trial services. They also invest services-for-equity.

Glysure

Oxfordshire, U.K.

Continuous glucose monitoring system using an intravascular, optical fluorescence-based sensor to support clinical implementation of Tight Glycemic Control and Intensive Insulin Therapy.

Histogenics Corporation

Waltham, MA

Histogenics is a leading regenerative medicine company that combines cell therapy and tissue engineering technologies to develop highly innovative products for tissue repair and regeneration. The company’s flagship products focus on the treatment of active patients suffering from articular cartilage derived pain and immobility.

Premia Spine

First Time Presenter

Ramat Poleg Netanya, Israel

Premia Spine is commercializing the TOPS™ System, an alternative to traditional fusion surgery for patients suffering from moderate to severe lumbar spinal stenosis.

Enox BioPharma

First Time Presenter

Vancouver, Canada

Enox Biopharma utilizes Nitric Oxide (NO) as an antimicrobial agent. NO is an ideal antimicrobial as it is highly effective, broad spectrum and does not have issues of antibiotic resistance. It can be dosed into medical devices after they have been manufactured and sterilized.

Intrinsic Therapeutics, Inc.

First Time Presenter

Woburn, MA

Intrinsic's Barricaid Prosthesis provides the added security of bone-anchored reconstruction that can be used to reconstruct larger regions of the anulus or in cases where anular integrity is in question.

Audax Medical

First Time Presenter

Littleton, MA

Our revolutionary approach to fracture repair works with the body to remodel and reestablish function in a patient's vertebra. Our products go beyond simply stabilizing a clinical deficiency by promoting the growth of natural bone and tissue. With our advancing intellectual property, enhanced surgical based solutions, and osteogenic biomaterial technologies, Audax offers a modern alternative to existing spinal and orthopedic therapies.

BovedaMarco Inc.

Fremont, CA

A multi-array catheter system to treat in a single setting patients presenting persistent/chronic atrial fibrillation allowing pulmonary vein ablation and left segmentation.

Marvao Medical

Galway, Ireland

Marvao Medical's NexSite CVC aims to significantly reduce infections, reduce hospital costs, extend vascular access longevity, and simplify patient care. NexSite technology enables a patient’s skin to fully heal into the catheter at its exit site, blocking this potential route for infection.

ThermopeutiX, Inc.

San Diego, CA

THERMOPEUTIX®, INC has developed a family of Cooltools™ that address the next frontiers in interventional medicine. The product line includes support/microcatheters and drug delivery systems to advance the treatment of vascular-related disorders, and a novel catheter system and technique for the treatment of ischemic brain injury (e.g., stroke, cardiac arrest, trauma).

CSA Medical Inc.

First Time Presenter

Baltimore, MD

Novel, Patented, FDA Cleared, Energy Based Medical System: Spray Cryotherapy.

Cequr Ltd.

Hellerup, Denmark

CeQur's lead product candidate is a small, wearable insulin delivery device that delivers both basal and bolus doses subcutaneously. Its simple and discrete design enables patients to more easily comply with insulin regimens and experience the benefits of intensive insulin therapy.

Nuubo

First Time Presenter

Madrid, Spain

Nuubo improves the lives of cardiac patients via a next-generation wireless remote monitoring platform. The solution is a proprietary, non-invasive and multi-leaded ECG system based on biomedical e-textile technology.

MC10, Inc.

First Time Presenter

Cambridge, MA

mc10 develops and promotes a new generation of thin, conformal electronics technology that endures bending, twisting, and stretching without sacrificing performance. The company has demonstrated these systems in a wide range of applications and is actively commercializing in the consumer and medical industries.

Fibralign Corporation

First Time Presenter

Sunnyvale, CA

High value implantable products created from proprietary fibrillar biopolymers (collagen, laminin, others) as well as supply these biopolymers to third parties and researchers.

Apeliotus Vision Science

First Time Presenter

Hershey, PA

Apeliotus is commercializing a simple diagnostic for early detection of a blinding eye disease called age-related macular degeneration (AMD), allowing intervention before the onset of significant vision loss.

Neurowave Systems, Inc.

First Time Presenter

Cleveland, OH

NeuroWave is proud to offer the NeuroSENSE® Monitor, the latest generation of brain monitors for patient-customized anesthesia and sedation, now cleared for sale in markets recognizing the CE mark.

Soft Tissue Regeneration, Inc.

New Haven, CT

Soft Tissue Regeneration, Inc. has developed a biocompatible and biodegradable scaffold to regenerate the anterior cruciate ligament ("ACL") of the knee.

LKC Technologies

First Time Presenter

Gaithersburg, MD

LKC Technologies is developing a breakthrough device to screen diabetics for diabetic retinopathy at the point of care. This device will allow a diabetic to be tested in their GP, Internist, Endocrinologist, or clinic in less than five minutes.

Intellectual Ventures

Bellevue, WA

The inventor teams at Intellectual Ventures have worked diligently for the better part of a decade developing ideas and inventions relating to medical devices, diagnostic tools and advancements for the life sciences.

CerviLenz

First Time Presenter

Chagrin Falls, OH

CerviLenz® is an innovative medical device that helps identify pregnant women at high risk for preterm birth and influence treatment.

LumiNIR, LLC

First Time Presenter

Ambler, PA

LumiNIR has developed a noninvasive, optical brain monitor for monitoring depth of anesthesia and level of sedation via direct measurement of deoxyhemoglobin and hemodynamic response.

Bone Biologics, Inc.

Thousand Oaks, CA

Bone Biologics is an orthobiologics company with a patented platform technology, UCB-1, a recombinant protein that regenerates bone and tissue.

Sphere Medical, Ltd.

Cambridge, UK

Company Description Coming Soon...

Angel Medical Systems

First Time Presenter

Shrewsbury, NJ

Company Description Coming Soon...

Dialog Devices, Ltd.

Loughborough, UK

Dialog Devices presents Padd for peripheral arterial disease assessment in Primary Care to prevent heart disease and stroke.

Health-Chem Diagnostics

First Time Presenter

Pompano Beach, FL

Non Invasive Blood Glucose System for Diabetic Self Testing.

Creaspine SAS

First Time Presenter

Pessac, France

Company Description Coming Soon...

Synthasome, Inc.

First Time Presenter

San Diego, CA

Synthasome is an emerging orthopaedic company developing and marketing innovative products for tendon, ligament and cartilage repair and regeneration.

Encapsule Medical Devices

First Time Presenter

Redwood City, CA

Company Description Coming Soon...

Cerbomed

First Time Presenter

Erlangen, Germany

Company Description Coming Soon...

BrainScope Company, Inc.

First Time Presenter

Bethesda, MD

The BrainScope Company, Inc. is developing a radically new generation of hand-held devices that operate as digital translators of the electrical activity of the brain - timely, mobile and out-at-edge.

Kerecis Limited

Reykjavik, Iceland

Novel tissue regeneration product for chronic wounds and hernia repair. Its patent pending fish skin derived material improves upon current human and porcine technologies through improved economics and clinical performance, reduced disease transfer risk and absence of cultural constraints on usage.

Arstasis Inc.

First Time Presenter

San Carlos, CA

Company Description Coming Soon...

Diagnostic Devices, Inc.

First Time Presenter

Simsbury, CT

Company Description Coming Soon...

PCAsso Diagnostics LLC

First Time Presenter

Bridgewater, NJ

PCAsso Diagnostics LLC is a New Jersey start-up diagnostics company developing PolyChromatic Angiography (PCA), the next generation quantitative retinal angiography.